| Name | CD44 |
|---|---|
| Synonyms | CD44; LHR; Heparan sulfate proteoglycan; CD44 antigen; CD44 antigen (Indian blood group); CD44 antigen (homing function and Indian blood group system); CD44 antigen precursor; CD44 molecule (Indian blood group)… |
| Name | ACC |
|---|---|
| CAS | 1-aminocyclopropanecarboxylic acid |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 17686280 | Liu K, Hua CG, Wen YM, Pan J, Chen SW, Gao QH: [Cancer stem cells: its existence, proliferation and differentiation in an adenoid cystic carcinoma cell line]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2007 May;42(5):284-7. The expression of CD44 (+) and CD24 (-) of ACC-2 cells were investigated by immunohistochemical. |
7(0,0,0,7) | Details |
| 17403031 | Bourguignon LY, Gilad E, Peyrollier K, Brightman A, Swanson RA: -CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes. J Neurochem. 2007 May;101(4):1002-17. Epub 2007 Mar 30. |
5(0,0,0,5) | Details |
| 20101228 | Tajima K, Ohashi R, Sekido Y, Hida T, Nara T, Hashimoto M, Iwakami S, Minakata K, Yae T, Takahashi F, Saya H, Takahashi K: Osteopontin-mediated enhanced binding induces multidrug resistance in mesothelioma cells. Oncogene. 2010 Apr 1;29(13):1941-51. Epub 2010 Jan 18. The expression of CD44 variant isoforms, which inhibit HA binding, significantly decreased in ACC-MESO-1/OPN cells in comparison to control transfectants. |
4(0,0,0,4) | Details |
| 20223349 | Defaud-Henon F, Tunon-de-Lara C, Fournier M, Marty M, Velasco V, de Mascarel I, MacGrogan G: [Adenoid cystic carcinoma of the breast: clinical, histological and immunohistochemical characterization]. Ann Pathol. 2010 Feb;30(1):7-16. Epub 2010 Feb 18. An immunohistochemical study was performed with the following antibodies: ER, PR, HER-2-neu, Vimentin, EGFR, P63, SMA, CK5/6, CK8/18, CK14, cKIT, MIB1, CD44 and CD24. |
1(0,0,0,1) | Details |